Navigation Links
Roche Completes Acquisition of BioVeris

Roche Diagnostics today announces that it has completed its acquisition of BioVeris. Roche signed the merger agreement with BioVeris for approximately $600 million on April 4, 2007.

This means Roche Diagnostics now owns the patents for Electrochemiluminescence (ECL) technology and can expand its immunochemistry business from the human diagnostics field into new market segments such as life sciences research, life science development, patient self-testing, veterinary testing, drug discovery, drug development and clinical trials.

"We are excited to be able to offer ECL technology to existing and new customers for these expanded uses. This is a highly innovative technology that our customers and their patients will certainly benefit from," said Andy Thomson, Senior Vice President, Centralized Diagnostics, Roche Diagnostics Corporation.

Today, Roche is a leader in immunochemistry, driven by its highly successful Elecsys(R) immunochemistry product line, the fastest growing portfolio of Roche Diagnostics' lab diagnostics business.


'"/>




Page: 1

Related medicine news :

1. FDA Imposes New Restrictions On Roches Accutane
2. Roche confirms Tamiflu production talks in US
3. Roche offers HIV drug expertise to poor nations
4. Roche Commits More Antiviral Pills To Asia For Bird Flu
5. Distinguished Scientist Award Conferred on University of Rochester Scientists for Work on Preventing Cavities
6. Roche Rolls Out Lung Cancer Drug In India
7. New Lung Cancer Drug Launched By Roche Pharmaceutical
8. Roche Calls For Re-Examination Of Tarceva Data By EU Authorities
9. Roche puts in an Application to Use Herceptin for Treatment in Her-2 positive breast cancer
10. NICE Gives the Final ‘NO’ to Roche’s Tarcva
11. Roche Announces Major Recall of HIV Drug
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2017)... ... 26, 2017 , ... New SUPRO® XT55 Isolated Soy ... by helping beverage manufacturers more effectively manage protein costs. “Soy protein has always ... well as more stable pricing over time. Now it’s even more relevant as ...
(Date:4/25/2017)... ... April 25, 2017 , ... Bellus ... that’s the first in a new class of photodynamic cosmetics (PDC). , Allumera® ... skin, visibly reduce outward signs of aging, and minimize the appearance of pores ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne research, ... cells) Phase I/II HOPE clinical trial in Duchenne announced today. , Coalition ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent ... test score performance for the 2015-16 school year across Wisconsin’s public schools, charter ... it highlights important patterns in student test score performance, the report’s limited analyses ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who ... achieves results in a fraction of the time as traditional braces – Wilckodontics®. ... Dental Specialists, now offers this revolutionary treatment with or without a referral. ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research and ... Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 Mn ... by 2024, expanding at a CAGR of 5.6% from 2016 ...
(Date:4/19/2017)... 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the ... Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in ... Chief Executive Officer of the Company is scheduled to present on ... Bear and the Chairman of the Board, Tony Holler ... ...
(Date:4/19/2017)... -- Global Surgical Drainage Device Market: Overview ... excess liquid and air. The fluid to be drained ... Surgical drains are used in a wide variety of ... surgery, neurosurgery, plastic surgery etc. Common use of surgical ... fluid e.g. blood or pus. Surgical drains are available ...
Breaking Medicine Technology: